World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
24989
World Ranking
1178
National Ranking
104

Medicine

D-Index
88
Citations
24994
World Ranking
13276
National Ranking
1235

Willem A. Hanekom publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Willem A. Hanekom sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 299 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Willem A. Hanekom D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Willem A. Hanekom sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa
  • Fellow of the Royal Society of South Africa

Overview

Willem A. Hanekom is affiliated with University College London in the United Kingdom. Their research primarily focuses on medicine, with a substantial body of work in immunology and microbiology. Within these domains, their contributions emphasize infectious diseases, immunology, and epidemiology, alongside work relevant to general health professions and surgery.

The scientist's research topics include:

  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Immune responses and vaccinations
  • COVID-19 Clinical Research Studies
  • Immunodeficiency and Autoimmune Disorders
  • HIV/AIDS Impact and Responses
  • HIV/AIDS Research and Interventions

Recent notable papers authored by Hanekom include:

  • "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization" (2021, Nature)
  • "Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma" (2021, Nature)
  • "SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection" (2021, bioRxiv (Cold Spring Harbor Laboratory))
  • "SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape" (2022, Cell Host & Microbe)
  • "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization" (2021, Nature)

Frequent co-authors in their research include:

  • Emily Wong
  • Khadija Khan
  • Alex Sigal
  • Thumbi Ndung'u
  • Farina Karim

The researcher has published extensively in various venues, most commonly in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Nature
  • Nature Communications
  • Wellcome Open Research

Willem A. Hanekom has received recognition as a Fellow of the Royal Society of South Africa. Their body of work spans over 160 publications in medicine and around 55 in immunology and microbiology, reflecting sustained engagement with infectious diseases and immune response research.

Best Publications

  • Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

    Michele D Tameris;Mark Hatherill;Bernard S Landry;Thomas J Scriba

  • A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

    Daniel E Zak;Adam Penn-Nicholson;Thomas J Scriba;Ethan Thompson

  • Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

    Elisa Nemes;Hennie Geldenhuys;Virginie Rozot;Kathryn T Rutkowski

  • Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.

    Sandile Cele;Inbal Gazy;Inbal Gazy;Laurelle Jackson;Shi-Hsia Hwa

  • Immunological biomarkers of tuberculosis.

    Gerhard Walzl;Katharina Ronacher;Willem Hanekom;Thomas J. Scriba

  • SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

    Unknown

  • Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response

    Thomas J. Scriba;Barbara Kalsdorf;Deborah-Ann Abrahams;Fatima Isaacs

  • Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns

    Benjamin M. N. Kagina;Brian Abel;Thomas J. Scriba;Elizabeth J. Hughes

  • Dominant TNF-α + Mycobacterium tuberculosis –specific CD4 + T cell responses discriminate between latent infection and active disease

    Alexandre Harari;Virginie Rozot;Felicitas Bellutti Enders;Matthieu Perreau

  • Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load

    Cheryl L. Day;Cheryl L. Day;Deborah A. Abrahams;Lesedi Lerumo;Esme Janse van Rensburg

  • T cells and adaptive immunity to Mycobacterium tuberculosis in humans

    Luke D. Jasenosky;Thomas J. Scriba;Willem A. Hanekom;Willem A. Hanekom;Anne E. Goldfeld

  • The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults

    Brian Abel;Michele Tameris;Nazma Mansoor;Sebastian Gelderbloem

  • T-cell activation is an immune correlate of risk in BCG vaccinated infants

    Helen A. Fletcher;Helen A. Fletcher;Margaret A. Snowden;Bernard Landry;Wasima Rida

  • COMPASS identifies T-cell subsets correlated with clinical outcomes

    Lin Lin;Greg Finak;Kevin Ushey;Chetan Seshadri

  • Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis

    Sara Suliman;Ethan G. Thompson;Jayne Sutherland;January Weiner rd

  • Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8 + T cells

    Lucy J. Walker;Yu-Hoi Kang;Matthew O. Smith;Hannah Tharmalingham

  • Bacillus Calmette-Guérin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles

    Andreia P. Soares;Thomas J. Scriba;Sarah Joseph;Ryhor Harbacheuski

  • Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

    Thomas J. Scriba;Michele Tameris;Nazma Mansoor;Erica Smit

  • Influence of BCG vaccine strain on the immune response and protection against tuberculosis

    Nicole Ritz;Nicole Ritz;Willem A. Hanekom;Roy Robins-Browne;Roy Robins-Browne;Warwick J. Britton

  • A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes

    Roshni Roy Chowdhury;Francesco Vallania;Qianting Yang;Cesar Joel Lopez Angel

  • The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in Children A Systematic Review and Meta-analysis

    Shingai Machingaidze;Charles Shey Wiysonge;Yulieth Gonzalez-Angulo;Mark Hatherill

  • Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa

    Tony Hawkridge;Thomas J. Scriba;Sebastian Gelderbloem;Erica Smit

Frequent Co-Authors

Thomas J. Scriba
Thomas J. Scriba University of Cape Town
Helen McShane
Helen McShane University of Oxford
Gerhard Walzl
Gerhard Walzl Stellenbosch University
Gilla Kaplan
Gilla Kaplan Bill & Melinda Gates Foundation
Cheryl L. Day
Cheryl L. Day Emory University
Helen A. Fletcher
Helen A. Fletcher London School of Hygiene & Tropical Medicine
Robert J. Wilkinson
Robert J. Wilkinson The Francis Crick Institute
W. Henry Boom
W. Henry Boom Case Western Reserve University
Thomas R. Hawn
Thomas R. Hawn University of Washington
Nigel Curtis
Nigel Curtis Royal Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open diverse career pathways. Many professionals consider advancing their credentials by enrolling in top pmhnp programs, which offer strong clinical placement rates and specialized psychiatric training. These programs are ideal for those looking to integrate immunological knowledge with mental health nursing.

Cost is often a significant factor, and finding the cheapest online pmhnp programs can make pursuing advanced practice nursing more accessible without compromising education quality. Balancing affordability with program reputation is key to long-term success.

Career growth is another important consideration. Understanding the dnp salary by state can help graduates make informed decisions about where to work and how to maximize their earning potential with a Doctor of Nursing Practice degree.

Moreover, nurses aiming to specialize further might consider transitioning certifications. Resources like the guide on fnp to acute care certification provide valuable steps for broadening clinical scope and enhancing patient care capabilities.

Exploring these options alongside immunology studies can enrich career prospects and empower healthcare professionals to make impactful contributions.

Best Scientists Citing Willem A. Hanekom

Trending Scientists